HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amebic monocyte locomotion inhibitory factor peptide ameliorates inflammation in CIA mouse model by downregulation of cell adhesion, inflammation/chemotaxis, and matrix metalloproteinases genes.

AbstractOBJECTIVE AND DESIGN:
Monocyte locomotion inhibitory factor (MLIF), an amebic peptide with antiinflammatory properties, was evaluated in collagen-induced arthritis (CIA) to test its effects on the onset and acute inflammatory response of arthritis.
MATERIAL:
DBA1/J mice at 8-10 weeks of age were divided into four groups (eight mice per group).
TREATMENT:
The adjuvant group received Freund adjuvant, the CIA group was immunized with collagen II, the MLIF/CIA group received collagen II and MLIF, and the MLIF group received MLIF and Freund adjuvant.
METHODS:
All groups were evaluated clinically. Seven weeks after the collagen injection, at the peak of the clinical arthritis score, limb specimens were collected and histological studies and gene expression analysis using microarrays were performed.
RESULTS:
MLIF administered weekly as a preventive scheme delayed and reduced the severity of acute arthritis. MLIF induced gene changes in functional categories including adhesion molecules, matrix metalloproteinases, and inflammatory cytokines.
CONCLUSIONS:
MLIF could be an interesting new molecule to investigate in the field of rheumatoid arthritis pathogenesis research for its potential to prevent inflammation.
AuthorsSusana Godina-Gonzalez, Janette Furuzawa-Carballeda, Dolores Utrera-Barillas, Jorge Alcocer-Varela, Luis M Teran, Monica Vazquez-del Mercado, Yelda A Leal, Isabel Alvarado-Cabrero, Juan R Velazquez
JournalInflammation research : official journal of the European Histamine Research Society ... [et al.] (Inflamm Res) Vol. 59 Issue 12 Pg. 1041-51 (Dec 2010) ISSN: 1420-908X [Electronic] Switzerland
PMID20582714 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Oligopeptides
  • monocyte locomotion inhibitory factor
  • Matrix Metalloproteinases
Topics
  • Animals
  • Arthritis, Experimental (drug therapy, pathology)
  • Cell Adhesion (drug effects)
  • Chemotaxis (drug effects)
  • Disease Models, Animal
  • Down-Regulation
  • Gene Expression Profiling
  • Gene Expression Regulation (drug effects)
  • Inflammation (drug therapy, pathology)
  • Male
  • Matrix Metalloproteinases (genetics)
  • Mice
  • Mice, Inbred DBA
  • Microarray Analysis
  • Oligopeptides (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: